BOLTON SECURITIES CORPORATION’s LeMaitre Vascular LMAT Stock Holding History

BOLTON SECURITIES CORPORATION’s Portfolio LMAT Stock Details LMAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	$4.56M	Buy	+54,390	New	+$5.06M	0.27%	96

Other funds holding LMAT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Conestoga Capital Advisors Wayne, Pennsylvania $3.31B AUM 6.07% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Copeland Capital Management Conshohocken, Pennsylvania $4.34B AUM 17.52% 1-Year Est. Return

Geneva Capital Management Milwaukee, Wisconsin $3.59B AUM 12.18% 1-Year Est. Return

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Congress Asset Management Boston, Massachusetts $15.4B AUM 30.39% 1-Year Est. Return

Ranger Investment Management Dallas, Texas $1.07B AUM 31.98% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

BOLTON SECURITIES CORPORATION's LMAT Position: Q1 2025 in Review

BOLTON SECURITIES CORPORATION opened a new position in LeMaitre Vascular (LMAT) in Q1 2025: 54,390 shares worth $4.56M. The stake represents 0.27% of the portfolio and ranks #96 among its holdings.

289 funds tracked by Wall St. Rank hold LMAT as of Q1 2025.

BOLTON SECURITIES CORPORATION held 54,390 shares of LeMaitre Vascular worth $4.56M as of Q1 2025.
LeMaitre Vascular was a new BOLTON SECURITIES CORPORATION position in Q1 2025.
LeMaitre Vascular made up 0.27% of BOLTON SECURITIES CORPORATION's portfolio in Q1 2025, its #96 holding.
289 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q1 2025.

Based on BOLTON SECURITIES CORPORATION's 13F filing for Q1 2025, filed 12 Nov 2026.